Advanced Development of Medical Countermeasures for Infectious Diseases - COVID-19 Related Studies

传染病医学对策的进展 - COVID-19相关研究

• 批准号: 10268793
• 负责人: GEORGE PAINTER
• 金额: $ 5.2万
• 依托单位: EMORY UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-09 至 2020-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10268793
• 关键词: 2019-nCoV; Advanced Development; COVID-19; Clinical; Communicable Diseases; Development; Influenza Therapeutic; Pathway interactions; Safety; medical countermeasure; pre-clinical; product development; research and development; therapeutic candidate

To support the advanced development of a promising candidate therapeutic. The research and development activities to be supported will allow the candidate therapeutic product to progress along the product development pathway, and include preclinical and IND enabling development activities, and clinical safety and efficacy assessment.

支持一种有前景的候选治疗药物的高级开发。待支持的研发活动将使候选治疗产品沿着产品开发途径推进，包括临床前和IND使能开发活动，以及临床安全性和有效性评估。